{"id":4150,"date":"2017-04-13T17:51:08","date_gmt":"2017-04-13T21:51:08","guid":{"rendered":"http:\/\/pmedicine.org\/journal\/?p=4150"},"modified":"2023-02-20T11:02:01","modified_gmt":"2023-02-20T16:02:01","slug":"the-future-of-patient-engagement-in-the-oncology-setting-how-practical-patient-engagement-recommendations-and-innovative-inter-professional-education-can-drive-change","status":"publish","type":"post","link":"https:\/\/participatorymedicine.org\/journal\/columns\/innovations\/2017\/04\/13\/the-future-of-patient-engagement-in-the-oncology-setting-how-practical-patient-engagement-recommendations-and-innovative-inter-professional-education-can-drive-change\/","title":{"rendered":"The Future of Patient Engagement in the Oncology Setting: How Practical Patient Engagement Recommendations and Innovative Inter-Professional Education Can Drive Change"},"content":{"rendered":"

Abstract<\/h3>\n

Summary<\/em><\/strong>: Patient engagement is a National Quality Strategy priority and is especially pertinent to oncology care, since cancer treatment can be complex and involves shared decision making between patients and different health care providers. However, patient engagement remains inconsistently and ineffectively implemented. We convened a round-table discussion with stakeholders and experts in patient engagement to address innovative, practical recommendations for patient engagement in oncology. We highlight emerging ways that provider and patient education can be delivered to support patient engagement, as well as research opportunities associated with engagement in oncology.
\nKeywords<\/em><\/strong>: Oncology, patient engagement, reimbursement, policy, shared decision making, learning health system.
\nCitation<\/em><\/strong>: Bosworth HB, Pini TM, Walters CB, Sih-Meynier R. The future of patient engagement in the oncology setting: how practical patient engagement recommendations and innovative inter-professional education can drive change. J Participat Med. 2017 Apr 11; 9:e7.
\nPublished<\/em><\/strong>: April 11, 2017.
\nCompeting Interests<\/em><\/strong>: Dr. Bosworth has received grant funding from Sanofi, Takeda, Improved Patient Outcomes that went to Duke University to cover costs of his research team to conduct research. Dr. Bosworth also received consulting funds from Sanofi, Regeneron Pharmaceuticals, CVS, Blue Cross\/Blue Shield of Arkansas, and Walgreens. Dr. Sih-Meynier is an employee at Genentech, Inc, and owns stock options. Dr. Pini is an employee of Premier, Inc, and owns stock options. Drs. Bosworth, Pini, and Burrows Walters received an honorarium from Genentech to participate in the roundtable that was used to generate ideas contained in the manuscript. The views expressed in this article are those of the author(s) and do not necessarily represent the position or policy of Duke University, the US Department of Veterans Affairs, or the US government.
\nFunding Sources<\/em><\/strong>: This project was funded by the Learning and Clinical Integration group within US Medical Affairs, Genentech, Inc. Dr. Bosworth was supported by a research career scientist award from VA Health Service Research and Development (VA HSR&D 08-027). Alexandra Howson MA, PhD, CHCP of Thistle Editorial, LLC, who was paid by Genentech, assisted in drafting and editing the manuscript. All authors confirm they have contributed to and reviewed the manuscript.<\/p>\n

Introduction<\/H3><\/p>\n

Widely recognized as a critical component of quality care, patient engagement has received growing attention in oncology. Patient engagement is being driven by legislative changes, payment reform, and federal mandates in health care that support the goals of the National Quality Strategy to improve quality of care, lower cost, and improve population health. <\/a>[1<\/a>] Broadly, patient engagement involves healthcare systems providing information and acknowledging individual preferences to enable patients to take actions and make decisions in order to obtain the greatest benefit from available healthcare (Center for Advancing Health\u2019s definition of patient engagement). <\/a>[2<\/a>] Patient engagement can help patients to make decisions and implement behavioral changes that result in improved satisfaction, <\/a>[3<\/a>] better outcomes, and lower costs of care. <\/a>[4<\/a>]<\/a>[5<\/a>] It is recognized that in order for patients to be engaged, both providers and patients need access to resources, tools, and education that foster engagement skills. <\/a>[6<\/a>]<\/a>[7<\/a>]<\/a>[8<\/a>] Shared decision-making is often considered a key component of patient engagement, <\/a>[9<\/a>] and is central to the Institute of Medicine\u2019s (IOM) framework for developing high-quality cancer care. <\/a>[10<\/a>] For the current paper, we focus predominantly on the patient-provider interaction, but acknowledge that engagement is broader and includes additional areas of focus such as asking questions, seeking out other sources of information, and challenging provider beliefs and decisions.<\/p>\n

Methods<\/H3><\/p>\n

While various stakeholders have called for health care reform that is patient-centric, there are few data on how oncology healthcare providers and systems can best implement strategies that support patient engagement. Therefore, we convened a round table of stakeholders and experts in patient engagement to identify evidence-based practical recommendations for patient engagement in oncology. Based on this discussion, we present innovative methods of delivering education for health care providers (HCPs) and patients, and review the advantages of the oncology medical home as a setting for engagement. <\/p>\n

Experts in oncology care and patient engagement were invited to join a working group to discuss the current state of patient engagement in the context of the CMS Oncology Care Model and other value-based payment models. <\/a>[11<\/a>] Experts were drawn from patient advocacy, Medical Oncology and Surgical Oncology, population health, informatics\/technology, patient education, oncology nursing, behavioral science, and research (see Appendix<\/a>). The goal of the meeting was to identify barriers and challenges that exist to engage patients in decision making for oncology care. Experts were asked to provide practical recommendations for oncology clinicians to engage with patients. The authors used these insights as a guide for identifying research questions that will need to be addressed to build an evidence base to support implementation of patient engagement in oncology.
\n

Findings<\/H3><\/p>\n

Unique Challenges to Patient Engagement in Oncology Settings<\/H4><\/p>\n

The nature of cancer care requires patients to process large amounts of information during times of distress while navigating a complex health care system. <\/a>[12<\/a>] Concomitantly, because cancer treatment necessitates multidisciplinary care, patients frequently have to take an active role in the coordination of their care. <\/a>[13<\/a>] In addition, the continuing evolution of cancer care to include oral chemotherapy and targeted therapy treatments, and the increase in the number of treatment options for both cancer-directed therapy and supportive management, necessitates greater reliance on patients and their caregivers to manage complex medical tasks. Patients\u2019 needs also change along the cancer continuum, requiring flexibility in how clinicians engage patients. <\/p>\n

Addressing the needs of patients when providing oncology care requires that the health care system, including infrastructure and processes of care, be designed to support patient engagement in meaningful ways. For instance, patient preferences should be incorporated when deciding on a treatment plan. This engagement practice can result in behavior changes with potential to improve both the quality of care and patient outcomes and reduce health care costs — the goals of the Triple Aim. <\/a>[14<\/a>] As such, patient engagement is a critical component in the shift toward value\u2013based care. However, as interest in shared decision making has increased, the goal is not to bend the cost curve alone, but rather to align treatment with patient preferences and improve quality of care. Similarly, shared decision making should not be a method for rationing of care. Both of these positions misrepresent the principles of shared decision making. <\/a>[15<\/a>] <\/p>\n

Patient Engagement as a Dimension of Value-Based Care<\/H4> <\/p>\n

Patient engagement is embedded in the Patient Protection and Affordable Care Act and is an integral component of care delivery to optimize population health management, deliver high-value care, and achieve success in value-based payment programs. These new reimbursement models provide a mechanism for providers and health care delivery networks to contract with payers in ways that reward providers for improvements in managing the health of their populations by coupling payment to outcomes, patient experience, and cost of care. <\/a>[16<\/a>]<\/p>\n

The Oncology Care Model (OCM) is a program that shares cost savings with oncology practices for episodes of care triggered by chemotherapy administration, if certain population health management services are in place, such as navigation and care plans, and high quality care is achieved. <\/a>[11<\/a>] The CMS Quality Payment Program begins in 2017 and will impact clinician payments starting in 2019, including payments to oncology providers. <\/a>[17<\/a>]<\/a>[18<\/a>] Clinician payment incentives and penalties will be based on the Merit Based Incentive Payment System, which will reward providers for high quality and efficient care, high patient experience scores, meaningful use of certified electronic health record (EHR) technology, and clinical practice improvement work. Commercial payers are also in the process of developing new payment models for cancer care. And most recently, CMS announced two new models specifically for patient engagement, the Shared Decision Making Model (SDM Model) and the Direct Decision Support Model (DDS Model). <\/a>[19<\/a>] As new payment models, aligned with quality domains and measures that prioritize patient engagement, begin to affect oncology practice, it is important that oncology providers implement strategies that support patient engagement. To this end, roundtable discussants identified several evidence-based interventions that provide an empowering and supportive environment that encourages patient engagement, and that oncology providers can consider implementing in their practice setting. <\/a>[20<\/a>] Coordination of oncology care places great burden on patients, their caregivers, and health care providers. Accordingly, communication is particularly important in oncology because patients\u2019 attitudes and preferences may change over the course of treatment and over time. <\/a>[10<\/a>] Studies, including a recent systematic review, show that clinician-focused education on how to employ patient-centered communication techniques can improve communication and engagement in cancer settings (Table 1). <\/a>[21<\/a>] These techniques include use of open-ended questions, demonstrating empathy to others, eliciting patient\u2019s values and preferences and ensuring understanding of options.<\/p>\n

Table 1. Strategies and Techniques that Support Patient Engagement Interactions. <\/strong><\/a>[21<\/a>]<\/p>\n

\"\"<\/a><\/p>\n

Best Practices to Support Effective Patient Engagement in Oncology<\/H4><\/p>\n

Communication Techniques. <\/strong><\/p>\n

These techniques include limiting the number of key points discussed in a visit to three or fewer, using the ask-tell-ask approach to establish clear goals, and to confirm and reinforce patient understanding. Similarly, providers can foster patient engagement by using open-ended questions to enable patients in clarifying their own priorities for care and making treatment choices that are fully informed and consistent with their personal preferences and values. Web-based, written, or multimedia decision tools have been shown to help patients decipher the risks and benefits of treatment and make decisions that are consistent with their preferences, values, and needs. <\/a>[10<\/a>] Patient-directed education on communication techniques can also help to build patients\u2019 confidence in asking questions that are critical to making health care decisions. <\/a>[21<\/a>]<\/p>\n

Communication Technology. <\/strong>
\nThe communication continuum in patient engagement needs to be non-disruptive and seamlessly integrated into a given practice environment. EHR systems can facilitate integration of patient engagement into practice by creating links between patient diagnoses and treatment plans, generating reports for clinical quality measures, integrating clinical decision support, and providing electronic messaging between providers. Patient portals can also facilitate patient engagement in the oncology setting. Patient portals allow for secure messaging between patients and providers, and exchange of patient-generated data, potentially improving communication and care while reducing the frequency of traditional in-office visits. <\/a>[20<\/a>] <\/p>\n

System Support for Health Literacy. <\/strong>
\nAt the system level, effective engagement interventions for patients with low health literacy include offering educational materials that adhere to best practices with regard to health literacy. Strategies for facilitating understanding include using large font, short sentences written in plain language, pictures, clear headings, and text written at a fifth-grade level. System level literacy support for patient engagement also includes using clinical information systems to provide real-time reminders during patient visits, <\/a>[22<\/a>] reduce patient burden by eliminating redundancy, and implementing medication reconciliation strategies (eg, simplifying medication regimens, using pill-boxes or other medication organizers, creating clear instructions about medications by using consistent pharmacy codes for order entry). <\/a>[23<\/a>] Table 2 summarizes roundtable recommendations for implementing patient engagement in oncology that are also supported in the literature. <\/p>\n

Table 2. Roundtable Recommendations for Implementing Patient Engagement in Oncology. <\/strong>
\n
\n\"\"<\/a><\/p>\n

New Models of Patient Engagement in Oncology. <\/strong>
\nInnovative patient care models in oncology based on patient-centered medical home (PCMH) principles are now showing evidence of effectiveness. For instance, a recent review concluded that the oncology PCMH can significantly reduce emergency room visits, hospital admissions, and overall costs among patients being treated with chemotherapy. <\/a>[30<\/a>] The essential feature of the PCMH model is to retain the primacy of an ongoing relationship between patients and their health care providers which may be extended beyond the core team and include nurses, social workers, dieticians and clinical support staff, with whom both the patient and oncologist have an ongoing relationship. Moreover, the PCMH approach is proactive in rigorously assessing for, and addressing health risk factors, and in removing barriers (eg, communication, physical, temporal, financial) between the patient and health care team (Table 3). <\/a>[31<\/a>]<\/p>\n

Table 3. Strategies to Remove Barriers between Patients and
\nProviders.<\/strong>
\n\"\"<\/a><\/p>\n

Notably, studies suggest that when the PCMH is implemented in ways that engage patients via real-time monitoring and interventions in between visits to reduce side effects and hospitalizations (eg, secure e-mail exchange and phone calls with care teams), patient experience, provider satisfaction, and efficiency are improved. <\/a>[31<\/a>] <\/p>\n

Discussion<\/h3>\n

Next Steps: Strategies for Implementing PE in Oncology<\/h4>\n

Continuing Education to Advance PE in Oncology.<\/strong>
\nAs the policy and reimbursement framework continues to evolve, continuing education can be an effective mechanism for educating providers about best practices in communication to support patient engagement. However, because patient engagement is a multidimensional process that occurs at many levels within and across health systems, such education also needs to include patients and their caregivers alongside clinicians. <\/a>[7<\/a>]<\/a>[32<\/a>] Health care educators are beginning to partner with patient advocacy organizations to develop tandem patient engagement, patient- and provider-directed education programs, and to create quality improvement programs that include patient engagement components. Such programs may collect and analyze engagement data (eg, via patient chart review; patient ratings of their providers\u2019 engagement skills; patient\/provider surveys to compare beliefs and values) in order to give personalized feedback to providers about their engagement skills and help them set personalized goals for behavioral change. <\/a>[33<\/a>]<\/a>[34<\/a>]<\/a>[35<\/a>] <\/p>\n

Building a Research Base for Patient Engagement in Oncology.<\/strong>
\nOncology providers need to consider their patient population and tailor patient engagement support to the specific individuals that they treat. Patients have heterogeneous needs which vary by demographics, comorbidities, location, level of family and caregiver support, literacy, culture, and goals of care. <\/a>[10<\/a>] Patients also vary in the degree of shared decision making they desire. Moreover, it remains unclear which universal metrics should be used to measure the effectiveness of patient engagement in oncology settings. <\/p>\n

Given these challenges and historical lack of implementation of shared decision making and engaging patients, roundtable discussants concluded that research is needed to examine innovative interventions to support patient engagement in a variety of cancer care delivery settings, and to address the following identified gaps:<\/p>\n